Dexamethasone Sodium Phosphate recalls

Dexamethasone Sodium Phosphate products have been recalled 4 times, most recently on 25 Mar 2026. The recalling company is usually West-Ward Pharmaceuticals. The most common reason is potency & assay.

Total recalls4since 2017
Last 12 months1reported
Class I00% of total
Ongoing2latest 25 Mar 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 50%Class III 2 50%

Why dexamethasone sodium phosphate is recalled

Product types

By year

Ongoing dexamethasone sodium phosphate recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium PhosphateSomerset TherapeuticsPotency & AssayNationwide
DrugCLASS IIDexamethasone Sodium Phosphate injection USP, 120mg recalled by Eugia USDexamethasone Sodium PhosphateEugia USPotency & AssayNationwide

All dexamethasone sodium phosphate recalls, newest first

4 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium PhosphateSomerset TherapeuticsPotency & AssayNationwide
DrugCLASS IIDexamethasone Sodium Phosphate injection USP, 120mg recalled by Eugia USDexamethasone Sodium PhosphateEugia USPotency & AssayNationwide
DrugCLASS IIIDexamethasone Sodium Phosphate Injection, USP, 20 mg recalledDexamethasone Sodium PhosphateWest-Ward PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDexamethasone Sodium Phosphate Injection, USP, 4 mg/mL Vials recalledDexamethasone Sodium PhosphateWest-Ward PharmaceuticalsPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.